ESC 365 - Copper chelation in hypertrophic cardiomyopathy; open-label pilot study assessing the effects of trientine on lv mass, myocardial fibrosis, performance and metabolism.

ESC Premium Access

Copper chelation in hypertrophic cardiomyopathy; open-label pilot study assessing the effects of trientine on lv mass, myocardial fibrosis, performance and metabolism.

Session: Poster session 5 - Cardiomyopathy

Topic: Cardiomyopathies

Speaker: Doctor A. Reid (Manchester, GB)

Event: ESC Congress 2017

Congress Presentation

Add to my library

About the speaker

Doctor Anna Reid

Manchester University NHS Foundation Trust, Manchester (United Kingdom of Great Britain & Northern Ireland)

1 presentation

1 follower

26 more presentations in this session

Sleep apnea diagnosis by using polysomnography may improve individual risk stratification in patients with hypertrophic cardiomyopathy

Speaker: Associate Professor T. Kara (Rochester, US)

Myocardial bridging in patients with apical hypertrophic cardiomyopathy

Speaker: Doctor S. Zhai (Beijing, CN)

Accuracy of LGE-CMR compared with histometric quantification of myocardial fibrosis in transplanted hearts of end-stage HCM

Speaker: Doctor G. Galati (Milan, IT)

Prevalence and progression of late gadolinium enhancement in children and adolescents with hypertrophic cardiomyopathy - a longitudinal study

Speaker: Doctor A. Axelsson Raja (Copenhagen, DK)

Prognostic role of myocardial edema at cardiac magnetic resonance in hypertrophic cardiomyopathy.

Speaker: Doctor G. Todiere (Pisa, IT)

Access the full session

Poster session 5 - Cardiomyopathy

Speakers: Doctor A. Reid, Associate Professor T. Kara, Doctor S. Zhai, Doctor G. Galati, Doctor A. Axelsson Raja...

About the event

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources